BiogenBIIB 
$197.53-0.34%24h
-0.34%24h
Global rank648
Market cap$28.58B
Change 7d-1.45%
YTD Performance-23.31%
SP500 benchmarkUnderperform
P/E24.78
P/S2.91
Revenue$9.84B
Earnings$1.16B
Dividend yield-
Main Sector
Healthcare
Category
Biogen (BIIB) Net Assets
BIIB Net Assets in 2023: $14.80B
As of 14 Nov 2024, Biogen net assets is $14.80B, an increase of 10.54% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Biogen overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Biogen Net Assets History from 2018 to 2024
-
Value:-
BIIB Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $14.80B | 10.54% |
| 2022 | $13.39B | 22.16% |
| 2021 | $10.96B | 2.56% |
| 2020 | $10.69B | -19.89% |
| 2019 | $13.34B | -16.72% |
| 2018 | $16.02B | - |
View the Top Net Assets Companies
